Elevance Health stock keeps guidance as Q3 earnings run ahead
AD HOC NEWS
Elevance Health has reiterated its 2026 adjusted EPS guidance of at least USD 27.00, despite third-quarter adjusted earnings tracking ahead of expectations. This continued guidance emphasizes the company's strong earnings execution and medical cost control. Elevance Health also reported Q2 adjusted EPS of USD 7.45, surpassing the consensus estimate, with the next earnings report scheduled for October 21, 2026.
Read the full story
This is a short summary. The complete article is published by AD HOC NEWS.
Headline and summary aggregated from public news feeds. For information only — not financial advice.